Physician profile
Joeli Link
NPI 1285033571
$4,315.87
in general payments reported to CMS, 2019-2025
31 companies · $1,986 in 2025
The $1,986 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.57 · 2023: $238 · 2024: $2,066 · 2025: $1,986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,290.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $472.84 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $300.21 | 2025 | |
| Merck Sharp & Dohme LLC | $293.57 | 2023-2025 | Verquvo, Capvaxive |
| Amgen INC. | $284.76 | 2023-2025 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $272.77 | 2024-2025 | Wainua, Farxiga |
| Novartis Pharmaceuticals Corporation | $257.37 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.90 | 2023-2025 | Jardiance |
| Philips North America LLC | $248.99 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, Mcot |
| Boston Scientific Corporation | $248.53 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Ingevity+ |
| Medtronic, INC. | $177.95 | 2024-2025 | Cobalt Dr Mri Surescan, Corevalve Evolut R, Linq II |
| Janssen Pharmaceuticals, INC | $162.73 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $152.28 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $149.91 | 2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.11 | 2023-2025 | Lifevest |
| Abbott Laboratories | $122.54 | 2025 | Jot Dx |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $113.73 | 2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $110.25 | 2024-2025 | Camzyos, Eliquis |
| Abiomed | $109.43 | 2024-2025 | Impella |
| Regeneron Healthcare Solutions, INC. | $70.52 | 2025 | Evkeeza |
| Bridgebio Pharma, INC. | $69.04 | 2025 | Attruby |
| Ionis Pharmaceuticals, INC. | $47.00 | 2025 | Tryngolza |
| Terumo Medical Corporation | $45.91 | 2024-2025 | Glidewire |
| Esperion Therapeutics, INC. | $35.30 | 2024-2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $35.13 | 2024 | |
| Scpharmaceuticals INC. | $32.73 | 2024 | |
| Abbvie INC. | $25.57 | 2022 | |
| Irhythm Technologies, INC. | $20.97 | 2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $18.38 | 2025 | Flowtriever |
| Glaxosmithkline, LLC. | $18.25 | 2025 | Arexvy, Shingrix |
| Collegium Pharmaceutical, INC. | $14.68 | 2023 | Xtampza |
| Heartflow, INC. | $13.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joeli Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.